To determine if the bispecific antibodies that target CHI3L1 and CTLA-4 particularly effective, we generated bispecific antibodies and their antitumor effects in a T cell-melanoma cell coculture system were evaluated and compared to individual antibodies, alone or in combination. Here, CHI3L1 is linked to melanoma.